Results 221 to 230 of about 74,737 (254)
Case Report: Guillain-Barré syndrome temporally associated with levofloxacin exposure and improvement following efgartigimod treatment. [PDF]
Xie S +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Guillain‐Barré Syndrome following ChAdOx1‐S/nCoV‐19 Vaccine
Annals of Neurology, 2021As of April 22, 2021, around 1.5 million individuals in three districts of Kerala, India had been vaccinated with COVID‐19 vaccines. Over 80% of these individuals (1.2 million) received the ChAdOx1‐S/nCoV‐19 vaccine.
Boby Varkey Maramattom +6 more
semanticscholar +1 more source
Diagnosis dan Tatalaksana Guillain Barré Syndrome
Lombok Medical JournalGuillain-Barré Syndrome or GBS is one of the emergency conditions of neurology. Currently, its incidence is relatively low and rare, with a rate of 0.81 to 1.89 of 100,000 people in a year. Guillain-Barré Syndrome or GBS, also known as acute inflammatory demyelinating polyradiculoneuropathy, is a collection of clinical symptoms caused by an acute ...
null Grandis Cristagalli +6 more
openaire +1 more source
ASEAN Journal of Psychiatry
Abstract Introduction: Guillain Barré Syndrome (GBS), has been commonly seen as a paraneoplastic manifestation in patients of small cell lung cancer. However, few published case reports of GBS are seldom re-ported in non-small cell lung cancer patients worldwide.
Dr. Nirmal Raut +2 more
openaire +1 more source
Abstract Introduction: Guillain Barré Syndrome (GBS), has been commonly seen as a paraneoplastic manifestation in patients of small cell lung cancer. However, few published case reports of GBS are seldom re-ported in non-small cell lung cancer patients worldwide.
Dr. Nirmal Raut +2 more
openaire +1 more source
Assessment of current diagnostic criteria for Guillain‐Barré syndrome
Annals of Neurology, 1990A. Asbury, D. Cornblath
semanticscholar +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly

